Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTLA
NTLA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTLA News
New CRISPR Technology Opens Opportunities in Biotech
2h ago
NASDAQ.COM
New CRISPR Technology Could Transform Market Dynamics
3h ago
Fool
Intellia Therapeutics Shares Surge 83% Amid Strong Clinical Progress
6d ago
Fool
Investor Sentiment Divided in Healthcare Sector
6d ago
seekingalpha
Short Sellers' Dilemma and Opportunities
Jun 24 2026
seekingalpha
Intellia Therapeutics Advances Gene Editing Treatment with Promising Phase 3 Results
Jun 24 2026
Fool
Intellia Therapeutics Advances Promising New Therapy
Jun 24 2026
NASDAQ.COM
Investment Choices in Gene Editing and Rare Disease Treatments
Jun 20 2026
NASDAQ.COM
Choosing Between Gene Editing and Orphan Disease Treatments
Jun 20 2026
Fool
Biotech Sector Sees FDA Approvals and Layoffs
Jun 19 2026
NASDAQ.COM
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
Jun 17 2026
Fool
Intellia Therapeutics' Drug Phase 3 Trial Success
Jun 17 2026
NASDAQ.COM
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
Jun 17 2026
Yahoo Finance
Regentis Soars After Withdrawing US Listing Application
Jun 16 2026
NASDAQ.COM
Intellia's Treatment Candidate Shows Promising Results
Jun 16 2026
Yahoo Finance
Lonvo-z Trial Shows Significant Quality of Life Improvements for Patients
Jun 15 2026
stocktwits
Show More News
